Cargando…

Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART

A new rapid assay for detecting oseltamivir resistance in influenza virus, iART, was used to test 149 clinical specimens. Results were obtained for 132, with iART indicating 41 as ‘resistant’. For these, sequence analysis found known and suspected markers of oseltamivir resistance, while no such mar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gubareva, Larisa V, Fallows, Eric, Mishin, Vasiliy P, Hodges, Erin, Brooks, Abdullah, Barnes, John, Fry, Alicia M, Kramp, William, Shively, Roxanne, Wentworth, David E, Weidemaier, Kristin, Jacobson, Ross
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2017
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434880/ https://www.ncbi.nlm.nih.gov/pubmed/28494845 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.18.30529

Ejemplares similares

Detection of oseltamivir‐resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test
por: Hodges, Erin N., et al.
Publicado: (2019)

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
por: Gubareva, Larisa V, et al.
Publicado: (2019)

IART: Inertial Assistant Referee and Trainer for Race Walking †
por: Caporaso, Teodorico, et al.
Publicado: (2020)

Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
por: Mohan, Teena, et al.
Publicado: (2021)

Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018
por: Jorquera, Patricia A., et al.
Publicado: (2019)

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
por: Mishin, Vasiliy P., et al.
Publicado: (2019)

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
por: Marjuki, Henju, et al.
Publicado: (2014)

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2015)

745. Surveillance for Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus Infections During 2016–2017 and 2017–2018, United States
por: Spencer, Sarah, et al.
Publicado: (2018)

Clinical and virologic outcomes in patients with oseltamivir‐resistant seasonal influenza A (H1N1) infections: results from a clinical trial
por: Dharan, Nila J., et al.
Publicado: (2011)

Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods
por: Patel, Mira C., et al.
Publicado: (2020)

Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States
por: Graitcer, Samuel B., et al.
Publicado: (2011)

Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO)
por: Paganelli, Giovanni
Publicado: (2017)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11
por: Storms, Aaron D., et al.
Publicado: (2012)

Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir
por: Patel, Mira C., et al.
Publicado: (2021)

An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance
por: Patel, Mira C., et al.
Publicado: (2022)

Antiviral Drug–Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016
por: Baranovich, Tatiana, et al.
Publicado: (2017)

A Patient Decision Aid (i.ARTs) to Facilitate Women’s Choice Between Oral and Long-Acting Injectable Antiretroviral Treatment for HIV: Protocols for its Development and Randomized Controlled Pilot Trial
por: Philbin, Morgan M, et al.
Publicado: (2022)

High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients
por: Bossard, Claire, et al.
Publicado: (2021)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico
por: Ramirez-Gonzalez, José Ernesto, et al.
Publicado: (2011)

Summer music and arts festivals as hot spots for measles transmission: experience from England and Wales, June to October 2016
por: le Polain de Waroux, Olivier, et al.
Publicado: (2016)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
por: Jang, Kyungho, et al.
Publicado: (2017)

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2011)

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2010)

Effectiveness of oseltamivir treatment on clinical failure in hospitalized patients with lower respiratory tract infection
por: Wiemken, Timothy L., et al.
Publicado: (2021)

Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial
por: McLean, Huong Q., et al.
Publicado: (2015)

A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses
por: De Marco, Donata, et al.
Publicado: (2012)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers
por: Chairat, Kalayanee, et al.
Publicado: (2016)

Oseltamivir dosing with haemofiltration
por: Tomlin, M, et al.
Publicado: (2010)

Chemical Analysis and Transplacental Transfer of Oseltamivir and Oseltamivir Carboxylic Acid in Pregnant Rats
por: Lin, Chia-Chun, et al.
Publicado: (2012)

Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins
por: Marjuki, Henju, et al.
Publicado: (2016)

IART(®) (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin
por: Paganelli, G, et al.
Publicado: (2010)

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022
por: Nguyen, Ha T., et al.
Publicado: (2023)

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2014)

A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
por: Clementi, Nicola, et al.
Publicado: (2011)

Update: Influenza Activity — United States, October 2, 2016–February 4, 2017
por: Blanton, Lenee, et al.
Publicado: (2017)

Assay to Detect Oseltamivir Resistance
por: Suwannakarn, Kamol, et al.
Publicado: (2006)

Rapid Emergence of Oseltamivir Resistance
por: Sy, Cheng Len, et al.
Publicado: (2010)

Oseltamivir in pregnancy and birth outcomes
por: Ehrenstein, Vera, et al.
Publicado: (2018)

Promising New Salt of Oseltamivir
por: Kalashnikov, A. I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tv9cm2hcts9aufo7i396nqnj8o